Kevin Slawin
Kevin M. Slawin (born 1961) is an American physician and the founder of Bellicum Pharmaceuticals and the Vanguard Urologic Institute at Memorial Hermann Medical Group. He is also the Director of Urology at Memorial Hermann Hospital. Slawin specializes in the diagnosis and treatment of urologic cancers and robotic surgery. He is also the co-inventor on several patents related to the advancement of prostate cancer diagnosis, staging and treatment and to the cellular immunotherapy of cancer.
primaryTopic
Kevin Slawin
Kevin M. Slawin (born 1961) is an American physician and the founder of Bellicum Pharmaceuticals and the Vanguard Urologic Institute at Memorial Hermann Medical Group. He is also the Director of Urology at Memorial Hermann Hospital. Slawin specializes in the diagnosis and treatment of urologic cancers and robotic surgery. He is also the co-inventor on several patents related to the advancement of prostate cancer diagnosis, staging and treatment and to the cellular immunotherapy of cancer.
has abstract
Kevin M. Slawin (born 1961) is ...... lular immunotherapy of cancer.
@en
birth date
birth place
birth year
occupation
Wikipage page ID
47,786,700
Wikipage revision ID
739,540,813
known for
Co-discoverer of P2PSA, a key ...... Bellicum Pharmaceuticals, Inc.
nationality
hypernym
comment
Kevin M. Slawin (born 1961) is ...... lular immunotherapy of cancer.
@en
label
Kevin Slawin
@en
wasDerivedFrom
gender
male
@en
givenName
Kevin
@en
isPrimaryTopicOf
name
Kevin M. Slawin
@en
Kevin Slawin
@en
surname
Slawin
@en